期刊文献+

CXCL13和CXCR5在骨缺损成骨微环境中的表达特征 被引量:3

Expression characteristics of CXCL13 and CXCR5 in osteogenic microenvironment of bone defect model
下载PDF
导出
摘要 目的研究CXCL13和CXCR5在骨缺损成骨微环境中的表达特征,为探索趋化因子调控成骨微环境与间充质干细胞行为提供依据。方法以20只新西兰白兔建立骨缺损模型,以脱蛋白骨移植修复。在术后1、2、4、8和12周分别取材,采用免疫组织化学SP法、Western blotting技术和Real-Time PCR分别检测CXCL13和CXCR5蛋白及mRNA的表达。结果免疫组织化学染色结果显示:CXCL13集中表达于载体支架与宿主骨床的修复界面;CXCR5在修复界面、髓腔及支架核心表达较强。Real-TimePCR检测结果显示:术后4周时,CXCL13和CXCR5 mRNA的表达与其他各时间点比较,差异有统计学意义(P<0.05)。Westernblotting检测结果显示:术后4周时,CXCL13和CXCR5蛋白表达水平最高。结论 CXCL13和CXCR5与成骨活跃程度相关,并表现为明显的时间与位点特征。 Objective To investigate the expression characteristics of CXCL13 and CXCR5 in osteogenic microenvironment of bone defect model, and provide evidence for their regulation effects on behavior of mesenchymal stem cells. Methods Twenty New Zealand rabbits were used for establishment of bone defect model, and restoration was conducted with deproteinized bone implantation. Samples were obtained 1 week, 2 weeks, 4 weeks, 8 weeks and 12 weeks after operation, and immunohistochemical SP method, Western blotting and Real-Time PCR were employed to determine the expression of CXCL13 and CXCR5 protein and mRNA. Results Immunohistochemical staining revealed that there was high expression of CXCL13 in the interface between scaffold and host bone, whereas there was high expression of CXCR5 in the interface, bone marrow and core of scaffold. Real-Time PCR indicated that the expression of CXCL13 and CXCR5 mRNA 4 weeks after operation was significantly different from that of the other time points ( P 〈 0.05). Western blotting demonstrated that the expression of CXCL13 and CXCR5 protein reached the peak 4 weeks after operation. Conclusion CXCL13 and CXCR5 are related to the level of osteogenic behavior, with typical characteristics of expression timing and location.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2012年第12期1536-1539,1548,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家自然科学基金(30700853) 上海市卫生局青年科研基金(044Y18)~~
关键词 骨缺损 微环境 趋化因子 CXCL13 CXCR5 bone defect microenvironment chemokine CXCL13 CXCR5
  • 相关文献

参考文献20

  • 1Schofield R. The relationship between the spleen colony-forming cell and the haematopoi-etic stem cell [ J ]. Blood Cells, 1978,4 ( 1 - 2) : 7 -25.
  • 2Deearis ML, Leach JK. Design of experiments approaeh to engineer cell-secreted matrices for directing ostengenic differentiation [ J ]. Ann Biomed Eng, 2011, 39(4) : 1174 - 1185.
  • 3Wang X, Yu YY, Lieu S, et al. MMP9 regulates the cellular response to inflammation after skeletal injury [ J ]. Bone, 2012, 52 (1): 111-119.
  • 4Khetan S, Burdick JA. Patterning network structure to spatially control cellular remodeling and stem cell fate within 3-dimensional hydrogels[ J]. Biomaterials, 2010, 31 (32) : 8228 - 8234.
  • 5Hambright D, Park KY, Brooks M, et al. Long-term survival and differentiation of retinal neurons derived from human embryonic stem cell lines in un-immunosuppressed mouse retina [ J ]. Mol Vis, 2012, 18(4) : 920 -936.
  • 6King W J, Kouris NA, Choi S, et al. Environmental parameters influence non-viral transfection of human mesenchymal stem cells for tissue engineering applications [ J ]. Cell Tissue Res, 2012, 347 (3) : 689 -699.
  • 7Liu Z, Wang H, Wang Y, et al. The influence of chitosan hydrogel on stem cell engraftment, survival anti homing in the ischemic myocardial microenvironment [ J]. Biomaterials, 2012, 33 ( 11 ) : 3093 - 3106.
  • 8Sehenk S, Mal N, Finan A, et al. Monoeyte ehemotactic protein-3 is amyocardial mesenchymal stem eell homing faetor [ J ]. Stem Cells, 2007, 25(1): 245-251.
  • 9Nishimura T, Simmons D J, Mainous EG. The origin of bone formed by heterotopic periosteal autografts [ J ]. J Oral Maxillofac Surg, 1997, 55( 11 ) : 1265 - 1268.
  • 10Kang Y, Kim S, Bishop J, et al. The osteogenic differentiation of human bone marrow MSCs on HUVEC-derived ECM anti β-TCP scaffold[ J]. Biomaterials, 2012, 33(29) : 6998 -7007.

同被引文献38

  • 1Agesen TH,Sveen A,Merok MA,et al.ColoGuideEx:a robust gene classifier specific for stage II colorectal cancer prognosis[J].Gut,2012,61(11):1560-1567.
  • 2Chaput N,Svrcek M,Auperin A,et al.Tumour-infiltrating CD+68and CD+57cells predict patient outcome in stage II-III colorectal cancer.Br J Cancer,2013,109(4):1013-1022.
  • 3Cho S,Song IH,Yang HC,et al.Prognostic factors of pulmonary metastasis from colorectal carcinoma[J].Interact Cardiovasc Thorac Surg,2013,17(2):303-307.
  • 4Breen EC,Fatahi S,Epeldegui M,et al.Elevated serum soluble CD30 precedes the development of AIDS-associated non-Hodgkin's B cell lymphoma[J].Tumour Biol,2006,27(4):187-194.
  • 5Widney DP,Breen EC,Boscardin WJ,et al.Serum levels of the homeostatic B cell chemokine,CXCL13,are elevated during HIV infection[J].J Interferon Cytokine Res,2005,25(11):702-706.
  • 6Burkle A,Niedermeier M,Schmitt-Graff A,et al.Overexpression of the CXCR5 chemokine receptor,and its ligand,CXCL13 in Bcell chronic lymphocytic leukemia[J].Blood,2007,110(9):3316-3325.
  • 7Razis E,Kalogeras KT,Kotoula V,et al.Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression[J].Clin Breast Cancer,2012,12(3):183-193.
  • 8Magliano MP,Logsdon CD.Roles for KRAS in pancreatic tumor development and progression[J].Gastroenterology,2013,144(6):1220-1229.
  • 9Demes M,Scheil-Bertram S,Bartsch H,et al.Signature of microsatellite instability,KRAS and BRAF gene mutations in German patients with locally advanced rectal adenocarcinoma before and after neoadjuvant 5-FU radiochemotherapy[J].J Gastrointest Oncol,2013,4(2):182-192.
  • 10Ouerhani S,Bougatef K,Soltani I,et al.The prevalence and prognostic significance of KRAS mutation in bladder cancer,chronic myeloid leukemia and colorectal cancer[J].Mol Biol Rep,2013,40(6):4109-4114.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部